CRBP

Covered Call on Call on Corbus Pharmaceuticals (NASDAQ:CRBP) - Potential income return 16.93% in 226 days (27.27% annualized)

CRBP biotech stocks
On October 19, 2020, we sold 1 covered call on CRBP stock expiring on April 16, 2021. For this trade, we got a $10 premium (before commissions). CRBP - a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system This trade comes as the #22 in the month of October, according to our trading plan for this month, the premium generated from this trade makes us about 1.26% from our $600 monthly goal, while in total we have already reached 66.…

Roll Forward Covered Call on Corbus Pharmaceuticals (NASDAQ:CRBP) - Potential income return 28.2% in 232 days (44.27% annualized)

CRBP biotech stocks
On October 19, 2020, we roll forwarded 1 covered call on CRBP stock with expiry on April 16, 2020. For this trade, we got a small $7.6 premium (after commissions). This trade was originally established as a credit spread on August 27, we got assinged 100 shares on September 14, 2020 and since then we have been selling covered calls This trade comes as the #21 in the month of October, according to our trading plan for this month, the premium generated from this trade makes us about 1.26% from…

Roll Forward 2 Covered Calls on Corbus Pharmaceuticals (NASDAQ:CRBP) - Potential income return 20.24% in 127 days (58.08% annualized)

CRBP biotech stocks
On October 19, 2020, we roll forwarded 2 covered calls on CRBP stock with expiry on January 15, 2020. For this trade, we got a small $11.2 premium (after commissions). This trade was originally established on September 10, buying 200 shares with CRBP at $2.49 per share, see: Covered Call on CRBP - Potential income return 9.04% in 8 days. Since then we have rolled this trade once: Roll Forward 2 Covered Calls on CRBP - Potential income return 18.15% in 35 days (189.12% annualized) This trade…

September 2020 Options Income Report - $715.35

CRBPBCRXAMCO dividend income
Here at OptionsBrew.com, we believe transparency is the key to success and that's why we have decided to share our monthly options income reports covering details behind the scenes. That said welcome to the fifth (#5) options income report. Last September we did in total 43 trades / from which most were covered calls and credit spreads There are 42 left open trades with expiry in the next months, with most (36) expiring in October. We managed to take $715.35 from options income during the…

Trading plan for October 2020 (Option trades & Stock Buys)

CRBP trading plan
Here at OptionsBrew.com, we believe a trading plan is already a 68% key to success. Without further ado, here is our trade plan for the upcoming month of October 2020. We are looking to buy an additional 13 shares of PFE for our Partnership fund.  At the end of the month, we should have 70 PFE stocks - once we will have 100 shares of PFE we will start selling covered calls on it, see: Covered Call Trade Idea with Weekly Options - Generate $45/week from this Dow Jones list Dividend Stock. …

Roll Forward 2 Covered Calls on CRBP - Potential income return 18.15% in 35 days (189.12% annualized)

CRBP roll forward
On September 21, 2020, we roll forwarded 2 covered calls on CRBP stock with expiry on October 16, 2020. For this trade, we got a $45.2 premium (after commissions). Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its pipeline of rationally designed, endocannabinoid system-targeting drug candidate This trade comes as the #28 in…

Covered Call on CRBP - Potential income return 63.21% in 50 days

CRBP biotech stocks
On September 14, 2020, we sold 1 covered call on CRBP stock expiring on October 16, 2020. For this trade, we got a $25 premium (before commissions). CRBP - a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system This trade comes as the #16 in the month of September, and if we stick with our trading plan for this month, the premium generated from this trade makes us about 2.9% from our $800 monthly goal, while in total we have…

Covered Call on CRBP - Potential income return 9.04% in 8 days

CRBP pharma stocks
On September 10, 2020, we sold 2 covered calls on CRBP stock expiring on September 18, 2020. For this trade, we got a $43.2 premium (after commissions). Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its pipeline of rationally designed, endocannabinoid system-targeting drug candidate This trade comes as the #14 in the month…

Update on CRBP Credit Spreads after stock falls more than 70%

CRBP pharma stocks
Corbus Pharmaceuticals (NASDAQ:CRBP) dropped more than 70% on September 8, 2020, in reaction to an unsuccessful Phase 3 clinical trial, RESOLVE-1, evaluating lead drug lenabasum in patients with a rare autoimmune disorder called diffuse cutaneous systemic sclerosis. As we are holding 2 credit spreads on CRBP stock, we decided to update our action plan. We are holding September 18 (6/5), and October 16 (5/4) expiry credit spreads Credit Spread on CRBP – 5.7% potential return in 22 days…

Credit Spread on CRBP – 8.64% potential return in 44 days

CRBP pharma stocks
On September 2, 2020, we sold a bull put credit spread on CRBP stock with options expiry set in the next 44 days. CRBP  - Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its pipeline of rationally designed, endocannabinoid system-targeting drug candidates Pharma and Biotech stocks have some juicy premiums, that's one of the…

Credit Spread on CRBP – 5.7% potential return in 22 days

CRBP pharma stocks
On August 27, 2020, we sold a bull put credit spread on CRBP stock with options expiry set in the next 30 days. CRBP  - Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its pipeline of rationally designed, endocannabinoid system-targeting drug candidates Pharma and Biotech stocks have some juicy premiums, thats one of the…